Site Initiation Visit Checklist: What Sponsors Miss (and How to Fix It)

The site initiation visit is the single most consequential day in a clinical trial site's lifecycle. It's the bridge between months of startup paperwork and the moment a site becomes authorized to enroll patients. Yet most SIV checklists used by sponsors and CROs haven't fundamentally changed in two decades. They cover the regulatory essentials — investigator brochure sign-off, delegation log review, drug accountability procedures — while systematically missing the training verification steps that actually predict whether a site will perform well or generate deviations for the next two years.

Why Most SIV Checklists Fall Short

Standard SIV checklists are built around compliance, not competency. They verify that documents exist, that signatures are collected, and that physical supplies are in place. These are necessary conditions for site activation, but they are not sufficient conditions for site success. A site can pass every item on a traditional SIV checklist and still generate protocol deviations in the first month of enrollment because no one verified that the coordinator actually understood the visit schedule or that the PI could articulate the eligibility criteria without looking them up.

The data supports this gap. A 2024 benchmarking survey by the Society for Clinical Research Sites (SCRS) found that 72% of sites reported feeling "inadequately prepared" for their first patient visit even after completing the SIV. The disconnect isn't that the SIV failed to happen — it's that the SIV covered logistics and paperwork without verifying operational readiness.

The traditional SIV tries to accomplish too much in a single day: regulatory review, protocol training, EDC walkthrough, lab kit review, IP management, and operational logistics. The result is a 6-8 hour marathon where critical training gets compressed into whatever time remains.

This compression creates a predictable failure mode. CRAs report spending an average of 45-60 minutes on protocol training during the SIV — far less than the 3-4 hours typically needed for complex Phase II/III protocols. The remainder of the time goes to document verification, system access setup, and regulatory review. Training becomes the item that gets squeezed when the day runs long, which it almost always does.

The Complete SIV Checklist: What to Add

The checklist below extends the standard SIV framework with the training verification and operational readiness items that most sponsors miss. Items marked with an asterisk (*) are the ones most commonly absent from traditional checklists.

Pre-SIV Preparation (2-4 Weeks Before)

• Protocol training completion verified* — All delegated staff have completed pre-SIV on-demand training modules and passed competency assessments before the SIV is scheduled
• Training completion certificates collected* — Documentation of protocol training completion is in the TMF before the CRA arrives on site
• Site-specific risk assessment completed* — CRA has reviewed the site's historical deviation data, prior audit findings, and staff experience level to customize the SIV agenda
• Pre-SIV knowledge gap analysis* — Results from on-demand training modules have been analyzed to identify which protocol areas need additional focus during the live SIV
• All required regulatory documents collected — IRB/EC approval, signed protocol, signed ICFs, CVs, medical licenses, financial disclosures, FDA Form 1572 (if applicable)
• EDC system access provisioned — All delegated staff have active accounts and have completed system training
• IVRS/IWRS access confirmed — Randomization system accounts are active and tested
• Lab kit inventory verified — Central lab kits are on site, within expiry, and accounted for
• IP shipment confirmed — Investigational product has been received, logged, and stored per protocol requirements

Regulatory and Documentation Review (Day Of)

• Delegation of Authority log review — Verify all listed staff are qualified, trained, and available; confirm delegation is specific to study tasks
• Informed consent form review — Walk through the ICF with the consent team; verify the approved version matches the IRB approval letter
• Essential document filing review — Confirm TMF/ISF structure; verify site knows where and how to file ongoing documents
• Signature log and specimen signature verification — Confirm all staff who will sign source documents or CRFs have current entries
• Site-specific amendment review* — If protocol amendments occurred between investigator meeting and SIV, verify site has received, reviewed, and implemented changes

Protocol Competency Verification (Day Of)*

• Eligibility criteria verbal walkthrough* — PI or Sub-I verbally explains key inclusion/exclusion criteria, including how to handle borderline cases; CRA asks scenario-based questions
• Visit schedule knowledge check* — Coordinator demonstrates ability to calculate visit windows from memory or using approved tools; CRA presents 2-3 scheduling scenarios
• Primary endpoint procedure review* — Staff responsible for primary endpoint data collection demonstrate the procedure step by step, not just acknowledge they read the manual
• Safety reporting workflow verification* — Walk through the complete SAE reporting chain from identification to sponsor notification; verify the site knows the reporting timeline and who to contact
• Prohibited medication awareness check* — Ask the PI to identify the most common prohibited concomitant medications and the process for managing patients who require them
• Protocol deviation reporting procedure* — Verify the site understands what constitutes a deviation, how to report one, and the difference between major and minor deviations

EDC and Data Collection Systems

• EDC system walkthrough — Complete a mock patient entry in the EDC system covering screening, enrollment, and at least one follow-up visit
• Query resolution process review — Demonstrate how to respond to data queries; verify the site understands expected response timelines
• Source document requirements review* — Walk through what constitutes acceptable source and where CRF data should originate; provide source document templates if available
• ePRO/eCOA device training* — If patient-reported outcomes are collected electronically, verify devices are charged, provisioned, and that staff can troubleshoot common patient issues

Investigational Product Management

• IP storage conditions verified — Temperature monitoring is active, storage unit meets specifications, backup procedures documented
• IP accountability procedure walkthrough — Pharmacist or designated staff demonstrates dispensing, return, and destruction procedures
• Blinding procedures review — If blinded, verify site understands emergency unblinding procedures and when they apply
• Dose modification/interruption rules* — Walk through the protocol's dose modification criteria with the treating physician; present 2-3 clinical scenarios

Operational Readiness

• Patient recruitment plan review* — Discuss the site's recruitment strategy, referral sources, and screening log process; set enrollment expectations
• After-hours contact procedures — Verify 24/7 patient access to a qualified investigator; confirm the SAE reporting chain after hours
• Staff backup plan verification* — Identify who covers for the primary coordinator and PI during absences; verify backup staff are delegated and trained
• Communication plan established* — Confirm preferred contact methods, regular check-in schedule, and escalation pathways between site, CRA, and sponsor

The Pre-SIV Training Model: Shifting the Burden

The most impactful change sponsors can make to their SIV process isn't adding more checklist items — it's fundamentally restructuring what happens before the CRA walks through the door. When sites complete interactive, on-demand protocol training in the weeks before the SIV, the live visit transforms from a compressed training session into a focused competency verification and operational readiness review.

This pre-SIV training model offers three distinct advantages. First, it eliminates the time pressure that forces CRAs to rush through protocol training. Second, it generates competency data that the CRA can use to customize the SIV agenda — spending more time on areas where the site's training scores indicate gaps and less time on areas the site has already mastered. Third, it creates a documented training record that satisfies regulatory requirements without relying on the CRA's subjective assessment of whether a 45-minute protocol overview was "adequate."

Sponsors who have adopted this model report that SIV duration decreases by 20-30% because the CRA isn't starting from scratch on protocol education. More importantly, the quality of the SIV interaction improves dramatically. Instead of lecturing, the CRA can ask probing questions, walk through complex scenarios, and verify hands-on competency — the activities that actually predict site performance. If you want to understand how this fits into the broader activation timeline, see our analysis of how pre-SIV training compresses site activation.

Common SIV Failures and How to Prevent Them

Even with a comprehensive checklist, certain SIV failure modes recur across the industry. Understanding these patterns helps sponsors and CRAs prepare more effectively.

Failure 1: The "PI-Only" SIV

The SIV is conducted with only the PI present, but the coordinator and other delegated staff — who will perform 90% of the day-to-day study procedures — are unavailable. Prevention: require all delegated study staff to attend the SIV as a condition of site activation. If scheduling conflicts make this impossible, the alternative staff must complete verified protocol training independently and the CRA must conduct a follow-up competency check before the site enrolls patients.

Failure 2: The "We'll Figure It Out" SIV

The CRA identifies knowledge gaps during the SIV but proceeds with site activation anyway, noting the gaps as "action items" to be resolved later. Prevention: establish clear, non-negotiable competency thresholds that must be met before site activation. If the site cannot demonstrate competency in critical areas (eligibility, primary endpoint, safety reporting), activation is paused until remediation is complete.

Failure 3: The "New Staff" Problem

The staff trained at the SIV leave the site or transfer to other studies within the first six months. New staff are onboarded with a brief handoff from existing team members but never receive formal protocol training. Prevention: deploy on-demand training modules that any new staff member can complete independently, with the same competency verification as original staff. The training platform should track who has been trained and automatically flag when delegated staff lack current training records.

Measuring SIV Effectiveness

A checklist is only useful if you measure whether it's working. Sponsors should track these four KPIs to evaluate their SIV process:

1. Time from SIV to first patient enrolled — shorter intervals suggest the site left the SIV operationally ready; long delays may indicate unresolved gaps
2. Protocol deviation rate in the first 90 days — the strongest indicator of whether SIV training was effective; deviations in this window are almost entirely attributable to training quality
3. First monitoring visit findings — the number and severity of findings at the first routine monitoring visit reflect how well the SIV prepared the site for independent operation
4. Site-reported confidence scores* — survey site staff after the SIV to assess their self-reported confidence in performing key procedures; sites that report low confidence need additional support before enrollment begins

Key Takeaways

The SIV checklist is one of the most underappreciated tools in clinical trial management. By expanding it beyond regulatory compliance to include training verification and operational readiness, sponsors can transform the SIV from a paperwork exercise into a genuine predictor of site success.

1. Add competency verification to your checklist — the items most commonly missing from SIV checklists are the ones that test whether site staff actually understand the protocol, not just that they signed the training log
2. Shift training before the SIV — on-demand interactive modules completed before the SIV free the live visit for verification, scenario review, and hands-on practice rather than passive education
3. Make activation contingent on demonstrated competency — sites that cannot demonstrate protocol knowledge should not be activated, regardless of regulatory readiness; the cost of delayed activation is far less than the cost of systematic deviations
4. Track SIV effectiveness with data — deviation rates, time to first patient, and monitoring visit findings tell you whether your SIV process is working; if these metrics aren't improving, your checklist needs revision